Vimarsana
Biggest News Aggregation in the World

Page 20 - Technology Development Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Technology Development Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Technology Development Group Today - Breaking & Trending Today

Apple is on the hunt for generative AI talent - Vimarsana News

Apple is on the hunt for generative AI talent

Apple currently has a dozen of job postings on its career page to look for experts in the field of generative AI.

Apple looking to hire machine learning engineers with an interest in generative AI - General Discussion Discussions on AppleInsider Forums - Vimarsana News

Apple looking to hire machine learning engineers with an interest in generative AI - General Discussion Discussions on AppleInsider Forums

Apple has to deal with the "AI race" just like every other tech company, which means it has to hire talent to help shape what that means for the company as a whole.

Apple hiring engineers with interest in generative AI - Vimarsana News

Apple hiring engineers with interest in generative AI

Apple has to deal with the "AI race" just like every other tech company, which means it has to hire talent to help shape what that means for the company as a whole. And, sure enough, the company's on the hunt.

Apple drops a MAJOR hint that it will launch a huge product next month - Vimarsana News

Apple drops a MAJOR hint that it will launch a huge product next month

Apple has shared the schedule for this year's Worldwide Developer Conference (WWDC) at Apple Park in California, which runs from June 5-9.

ImmPACT Bio Announces Opening of California-Based GMP Facility for Clinical Production of IMPT-314, a CD19/CD20 CAR T Therapy for B-Cell Malignancies and Autoimmune Diseases - Vimarsana News

ImmPACT Bio Announces Opening of California-Based GMP Facility for Clinical Production of IMPT-314, a CD19/CD20 CAR T Therapy for B-Cell Malignancies and Autoimmune Diseases

/PRNewswire/ -- ImmPACT Bio USA, Inc. ("ImmPACT Bio"), a clinical-stage company developing transformative logic-gate-based chimeric antigen receptor (CAR)...